LAS VEGAS, Aug. 15, 2011 /PRNewswire/ -- Gamma Pharmaceuticals Inc. (NASDAQ: GMPM.PK), a marketing and product formulation company selling its own branded products through wholesalers and direct to retailers, announced today, the Company accepted purchase orders from three counterparties and expects more in the weeks to come. The Company also signed a distribution agreement for the South-central and the Southwest US market. Importantly, Gamma completed a manufacturing run for its Gamma Energy Gel, which will be in retail outlets in the New York metropolitan region, Northern California and Texas.

Individually, each of these accomplishments is a noteworthy achievement in the Company’s annual plan; collectively, they represent a significant step forward. The Company is utilizing the credit facility announced earlier this year to finance working capital.

About Gamma Pharmaceuticals Inc.

Gamma Pharmaceuticals, Inc., (www.gammapharma.com) is a marketing and product formulation company selling its own branded products through wholesalers and direct to retailers, both in the US and internationally. Gamma’s core focus is the marketing and sale of vitamins and nutriceuticals, OTC pharmaceutical products and personal care products in the United States. Branded nutritional supplements are sold under the trademarks Brilliant Choice nutritional supplements featuring the call to action “You’ve made a brilliant choice for your nutrition;" SAVVY adult nutritional supplements featuring the call to action, “Be SAVVY Stay Healthy;" and, Gamma Energy Products a high performance supplement featuring the call to action, “Get Your Gamma On.” Gamma’s customer focus is on selling products in the Lifestyle of Health & Sustainability (“LOHAS”) marketplace and in the Energy Supplement Market. A series of innovative marketing programs supports Gamma’s product sales and retail partners.

At present Gamma manufactures in North America, and distributes in the United States. Gamma’s products utilize proprietary “Gel Delivery Technology®", to create innovative gel product forms; that give consumers a more pleasant experience. Gel Delivery Technology® characteristics include rapid absorption, convenience and taste great. Market categories Gamma targets are growing as rapidly as 60% per year. Gamma has developed formulas and strategies for Metabolic Syndrome and Diabetes Type II, Stress Reduction, Cognition, Well being, Menopause Symptoms and Personal Care Products. Gamma also develops and manufactures house brands for major retailers. At this time, Gamma has a total of 36 SKU’s and holds licenses for 9 SKUs in China.

Forward-Looking Statements: This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The statements in this Press Release regarding any impact the quotation of the Company’s stock has on the Pink Sheets or the lack thereof on the OTCBB, and any other effects of the above are forward-looking statements. Such statements are subject to certain risks and uncertainties, and actual circumstances, events or results may differ materially from those projected in such forward-looking statements. The Company cautions readers not to place undue reliance on any forward-looking statements. The Company does not undertake, and specifically disclaims any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.

Contact: Gamma Pharmaceuticals Inc.
Joe Cunningham, CFO (jcunningham@gammapharma.com)
Direct: (651) 204 2048
Office: (702) 989 5262

SOURCE Gamma Pharmaceuticals Inc.